Weigen Lu

922 total citations
29 papers, 768 citations indexed

About

Weigen Lu is a scholar working on Biomaterials, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Weigen Lu has authored 29 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomaterials, 8 papers in Molecular Biology and 5 papers in Pharmaceutical Science. Recurrent topics in Weigen Lu's work include Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (4 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Weigen Lu is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (4 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Weigen Lu collaborates with scholars based in China, South Korea and Japan. Weigen Lu's co-authors include Jing Qin, Yujie Zhang, Qin Guo, Yu Zhang, Han Y. H. Chen, Yifei Lü, Qinjun Chen, Chen Jiang, Tao Sun and Rong Xu and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and ACS Applied Materials & Interfaces.

In The Last Decade

Weigen Lu

28 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weigen Lu China 13 260 222 162 162 146 29 768
Xiaowei Lu China 15 364 1.4× 226 1.0× 87 0.5× 99 0.6× 69 0.5× 39 916
Ziming Zhao China 21 374 1.4× 333 1.5× 145 0.9× 218 1.3× 38 0.3× 56 1.1k
Meng Huang China 14 369 1.4× 236 1.1× 80 0.5× 169 1.0× 75 0.5× 26 853
Wan Xu China 11 345 1.3× 309 1.4× 159 1.0× 163 1.0× 43 0.3× 13 784
Yang Deng China 16 397 1.5× 219 1.0× 79 0.5× 201 1.2× 39 0.3× 28 889
Shiyao Fu China 15 350 1.3× 280 1.3× 51 0.3× 269 1.7× 46 0.3× 24 783
Amira Sayed Hanafy Egypt 10 164 0.6× 124 0.6× 210 1.3× 75 0.5× 57 0.4× 18 596
Bruna dos Santos Rodrigues United States 13 471 1.8× 302 1.4× 78 0.5× 154 1.0× 60 0.4× 29 798
Yongji Li China 15 207 0.8× 152 0.7× 99 0.6× 99 0.6× 41 0.3× 38 591

Countries citing papers authored by Weigen Lu

Since Specialization
Citations

This map shows the geographic impact of Weigen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weigen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weigen Lu more than expected).

Fields of papers citing papers by Weigen Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weigen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weigen Lu. The network helps show where Weigen Lu may publish in the future.

Co-authorship network of co-authors of Weigen Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Weigen Lu. A scholar is included among the top collaborators of Weigen Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weigen Lu. Weigen Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jie, Xiaoling Liu, Hongping Qu, et al.. (2025). Designed microchannel-based lipid nanoparticles encapsulated siRNA targeting gasdermin D for sepsis management via pulmonary delivery. Nano Today. 61. 102653–102653. 1 indexed citations
2.
Yang, Li, Miaomiao Zhang, Shiyi Li, et al.. (2023). Selective ischemic-hemisphere targeting Ginkgolide B liposomes with improved solubility and therapeutic efficacy for cerebral ischemia-reperfusion injury. Asian Journal of Pharmaceutical Sciences. 18(2). 100783–100783. 26 indexed citations
3.
Zhao, Yuezhu, Jie Liu, Weiwei Zhang, et al.. (2022). Novel Self-Assembled Micelles With Increased Tumor Penetration and Anti-Tumor Efficiency Against Breast Cancer. Pharmaceutical Research. 39(9). 2227–2246. 6 indexed citations
4.
Yang, Qiuxia, et al.. (2022). Structure–property relationship in the evaluation of xanthan gum functionality for oral suspensions and tablets. International Journal of Biological Macromolecules. 226. 525–534. 7 indexed citations
5.
Huang, Lele, Zhen Li, Wenli Zhang, et al.. (2022). Multifunctional ROS-Responsive and TME-Modulated Lipid-Polymer Hybrid Nanoparticles for Enhanced Tumor Penetration. International Journal of Nanomedicine. Volume 17. 5883–5897. 10 indexed citations
6.
He, Jun, et al.. (2022). Novel Docetaxel-Loaded Micelles Based on all-trans-Retinoic Acid: Preparation and Pharmacokinetic Study in Rats. SHILAP Revista de lepidopterología. 4(3). e188–e196. 2 indexed citations
7.
Lu, Weigen, et al.. (2021). Synthesis of a Novel PTH1–34 Analog with Increased Human Serum Albumin Affinity. SHILAP Revista de lepidopterología. 3(1). e23–e29. 1 indexed citations
8.
Wu, Fan, et al.. (2019). <p>Development of a stable single-vial liposomal formulation for vincristine</p>. International Journal of Nanomedicine. Volume 14. 4461–4474. 19 indexed citations
9.
Gao, Caifang, Jianming Liang, Ying Zhu, et al.. (2019). Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy. Acta Pharmaceutica Sinica B. 9(4). 843–857. 61 indexed citations
10.
Liang, Jianming, Ying Zhu, Caifang Gao, et al.. (2019). Menthol-modified BSA nanoparticles for glioma targeting therapy using an energy restriction strategy. NPG Asia Materials. 11(1). 32 indexed citations
11.
Liang, Jianming, Caifang Gao, Ying Zhu, et al.. (2018). Natural Brain Penetration Enhancer-Modified Albumin Nanoparticles for Glioma Targeting Delivery. ACS Applied Materials & Interfaces. 10(36). 30201–30213. 54 indexed citations
12.
Lu, Weigen. (2012). Advance on efflux inhibitors inhibiting ABC transporters to improve drug intestinal absorption. 2 indexed citations
13.
Lu, Weigen. (2011). Determination of helicid in rat plasma by ultra performance liquid chromatography-tandem mass spectrometry. 1 indexed citations
14.
Lu, Weigen. (2011). Salt Screening in Drug Development Process. Chinese Journal of Pharmaceuticals. 1 indexed citations
15.
Lu, Weigen, Lili Wang, Li Chen, et al.. (2010). Enhancing Oral Bioavailability of Methylnaltrexone Using an Emulsion Formulation. Letters in Drug Design & Discovery. 8(1). 87–92. 4 indexed citations
16.
Lu, Weigen. (2008). Study on Oral Bioavailability of Baicalin in Rats. Zhōnghuá yàoxué zázhì. 5 indexed citations
17.
Qin, Jing, Dawei Chen, Weigen Lu, et al.. (2008). Preparation, Characterization, and Evaluation of Liposomal Ferulic Acid In Vitro and In Vivo. Drug Development and Industrial Pharmacy. 34(6). 602–608. 27 indexed citations
18.
Lu, Weigen, et al.. (2008). Distribution of an intravenous injectable nimodipine nanosuspension in mice. Journal of Pharmacy and Pharmacology. 60(9). 1155–1159. 15 indexed citations
19.
Lu, Weigen, et al.. (2007). Preparation and characterization of intravenously injectable nimodipine nanosuspension. International Journal of Pharmaceutics. 350(1-2). 338–343. 97 indexed citations
20.
He, Jun, et al.. (2007). Preparation, Pharmacokinetics and Body Distribution of Silymarin-Loaded Solid Lipid Nanoparticles After Oral Administration. Journal of Biomedical Nanotechnology. 3(2). 195–202. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026